Evaluating third-party analytical documentation is essential when procuring synthetic peptides for biochemical and cellular assays. A Certificate of Analysis (COA) for Snap-8 provides verifiable laboratory data regarding chemical identity, chromatographic purity, mass verification, and bioburden controls. This guide detail the key parameters included on a PX1 Research Snap-8 COA and their relevance to rigorous preclinical research.
Evaluating third-party analytical documentation is essential when procuring synthetic peptides for biochemical and cellular assays. A Certificate of Analysis (COA) for Snap-8 provides verifiable laboratory data regarding chemical identity, chromatographic purity, mass verification, and bioburden controls. This guide detail the key parameters included on a PX1 Research Snap-8 COA and their relevance to rigorous preclinical research.
A Snap-8 Certificate of Analysis (COA) is an official analytical document produced by an independent, ISO 17025-accredited testing laboratory that verifies the identity, purity, and quality of a specific batch of synthetic Acetyl Octapeptide-3. The COA confirms that the peptide batch matches its theoretical molecular weight via mass spectrometry, meets stringent purity thresholds (typically ≥98%) via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), and maintains minimal bacterial endotoxin levels for reliable in vitro experimentation.
For investigators evaluating incoming reagents, a valid COA serves as the definitive record of chemical integrity. Without lot-specific analytical verification, researchers risk introducing uncharacterized peptide fragments, counterion impurities, or endotoxin contaminants into cellular assays, which can skew experimental results. PX1 Research publishes lot-traceable documentation for every batch of Snap-8 10mg supplied across our catalog of research peptides.
Snap-8, systematically designated as Acetyl Octapeptide-3 (or Acetyl Glutamyl-Glutamyl-Methionyl-Glutaminyl-Arginyl-Arginyl-Alanyl-Aspartamide), is an octapeptide derived from the N-terminal end of the SNAP-25 protein. It features an acetylated N-terminus and an amidated C-terminus, modifications designed to enhance metabolic stability against exopeptidases during in vitro testing.
The theoretical molecular weight of Snap-8 is approximately 1075.16 g/mol, with a chemical formula of C41H70N16O16S. Preclinical data indicate that its specific primary sequence allows it to mimic the native domain of SNAP-25, competing for binding sites within the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) complex. When procuring this agent, researchers must review the COA to ensure that the measured monoisotopic or average molecular mass aligns precisely with calculated specifications.
In cell-free and cell-culture models, Snap-8 functions as a competitive inhibitor of SNARE complex assembly. The SNARE complex is a macromolecular protein bundle consisting of SNAP-25, synaptobrevin, and syntaxin, which mediates the docking and fusion of synaptic vesicles with the presynaptic membrane, facilitating neurotransmitter exocytosis.
In vitro assays demonstrate that by mimicking the N-terminal sequence of SNAP-25, Snap-8 destabilizes the ternary SNARE complex. As a result, vesicular fusion rates and catecholamine release are attenuated in neuronal cell lines (such as PC12 cells). Researchers investigating neuroexocytosis, vesicle trafficking, and membrane fusion kinetics utilize Snap-8 as a target-specific biochemical tool. Detailed background on related pathways can be explored in our PX1 Research library hub.
A rigorous Certificate of Analysis goes beyond basic appearance checks. To guarantee lot-to-lot consistency, PX1 Research subjects all peptide lots to multi-method quantitative testing. Every COA includes specific metrics that document physical state, chemical composition, and biological purity.
Key data fields provided on a standard Snap-8 COA include:
• Product Name and Chemical Identifier: Acetyl Octapeptide-3 / Snap-8 • Lot/Batch Number: Unique identifier corresponding directly to the vial label • Appearance: Verification of a lyophilized, white to off-white cake or powder • RP-HPLC Purity Percentage: Quantified area under the curve (AUC) demonstrating peptide purity relative to synthesis byproducts • ESI-MS Mass Confirmation: Electrospray ionization mass spectrometry showing observed mass vs. theoretical mass • Bacterial Endotoxin Level: Kinetic Chromogenic LAL assay result expressed in EU/mg • Counterion and Moisture Content: Quantitative evaluation of trifluoroacetate (TFA) or acetate salts and residual moisture
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for determining the chromatographic purity of synthetic peptides. During RP-HPLC, the Snap-8 sample is injected into a hydrophobic stationary phase column and eluted using a gradient of organic solvent (typically acetonitrile with 0.1% trifluoroacetate).
The resulting chromatogram displays a primary peak corresponding to intact Acetyl Octapeptide-3, alongside any minor secondary peaks representing deletion sequences, truncated peptides, or oxidation products (such as methionine sulfoxide derivatives). PX1 Research mandates a minimum purity threshold of ≥98.0% by RP-HPLC area percent. For full transparency on testing standards, consult our technical guide on HPLC and mass spectrometry testing protocols.
While HPLC quantifies purity levels, Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) confirms molecular identity. Mass spectrometry measures the mass-to-charge ratio (m/z) of the peptide ion species present in the sample.
On a Snap-8 COA, the MS spectrum must exhibit a predominant ion peak corresponding to the protonated molecule [M+H]+ at ~1076.2 m/z, or doubly charged species [M+2H]2+ at ~538.6 m/z. The absence of unexpected high-intensity mass peaks confirms that the synthesized material matches the exact target sequence without amino acid substitutions or incomplete protecting group deprotection.
Endotoxins, specifically lipopolysaccharides (LPS) derived from Gram-negative bacterial outer membranes, represent a significant confounding variable in cell culture research. Excessive endotoxin levels can trigger non-specific inflammatory signaling, alter receptor expression, and invalidate in vitro findings.
PX1 Research performs Limulus Amebocyte Lysate (LAL) testing on every peptide lot. The resulting COA reports the exact endotoxin concentration, typically restricted to <0.05 EU/mg. Enforcing strict endotoxin thresholds ensures that observed physiological responses in cell assays are attributable solely to the target compound rather than bacterial contamination.
Snap-8 belongs to a broader class of SNARE complex peptide analogs evaluated for their ability to modulate exocytosis in preclinical models. When designing comparative studies, researchers frequently compare Snap-8 against structurally distinct or shorter-chain sequence variants.
For example, Argireline (Acetyl Hexapeptide-8) consists of a shorter six-amino-acid sequence derived from SNAP-25. In vitro inhibition assays indicate that Snap-8 demonstrates approximately 30% greater potency than Argireline in inhibiting SNARE complex assembly due to its extended length and enhanced binding affinity. Another related compound, Leuphasyl (Pentapeptide-3), operates through an entirely distinct pathway by mimicking enkephalin signaling to modulate neuronal excitability. Evaluating COAs across these related peptides allows researchers to select compounds with matching purity profiles and verified structural identities for controlled head-to-head assays.
To preserve the integrity documented on the COA, laboratory personnel must follow standard peptide handling protocols upon receipt. Lyophilized Snap-8 should be stored at -20°C or -80°C in a desiccated environment away from light, where it remains stable for extended periods.
For reconstitution, vials should be equilibrated to room temperature prior to opening to prevent atmospheric moisture condensation. The lyophilized cake is typically soluble in sterile bacteriostatic water, sterile normal saline, or standard aqueous buffers (such as PBS, pH 7.4). Once reconstituted, liquid aliquots should be frozen at -20°C to avoid repeated freeze-thaw cycles, which can cause peptide degradation or aggregation. Laboratories requiring large quantities for ongoing protocols can establish dedicated supply channels via our bulk laboratory account options.
PX1 Research prioritizes rigorous quality control and batch consistency. All research compounds, including Snap-8, are manufactured in state-of-the-art, GMP-compliant facilities located within the United States. Every production lot undergoes independent verification by third-party ISO 17025 accredited laboratories before release.
Orders are fulfilled directly from our domestic distribution centers in California and Arizona, with same-day shipping available for orders placed Monday through Friday before 12:00 PM PST. By maintaining strict control over synthesis, analytical verification, and storage environment, PX1 Research delivers reliable reagents for advanced preclinical investigation.
What is a Snap-8 COA and why is it necessary for research?
A Snap-8 COA (Certificate of Analysis) is an official third-party document providing lot-specific test data, including RP-HPLC purity percentage, ESI-MS identity verification, and endotoxin levels. It is necessary for researchers to verify reagent purity and ensure reproducible experimental results.
Where can I find the COA for my specific batch of Snap-8 from PX1 Research?
PX1 Research provides lot-specific COAs for every peptide order. The COA can be downloaded directly from the product page or accessed by scanning the batch QR code printed on the physical vial label.
What purity level is guaranteed on a Snap-8 COA from PX1 Research?
PX1 Research guarantees a minimum purity threshold of ≥98.0% as measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for all Snap-8 lots.
How is the chemical identity of Snap-8 confirmed on the COA?
Identity is confirmed using Electrospray Ionization Mass Spectrometry (ESI-MS). The spectrum must demonstrate a mass peak matching the theoretical molecular weight of Acetyl Octapeptide-3 (~1075.16 g/mol).
What endotoxin limit is acceptable on a laboratory peptide COA?
For cell culture and in vitro research, endotoxin levels should ideally remain below 0.1 EU/mg. PX1 Research tests every lot using LAL assays, with typical levels measuring <0.05 EU/mg.
What is the difference between Snap-8 and Argireline in preclinical studies?
Snap-8 (Acetyl Octapeptide-3) is an extended 8-amino-acid sequence, whereas Argireline (Acetyl Hexapeptide-8) is a 6-amino-acid peptide. In vitro assays suggest Snap-8 exhibits higher potency in inhibiting SNARE complex formation due to enhanced steric hindrance.
How should lyophilized Snap-8 be stored upon delivery?
Lyophilized Snap-8 should be stored at -20°C or -80°C in a dry, dark environment. Reconstituted solution aliquots should be stored at -20°C and protected from repeated freeze-thaw cycles.
Are PX1 Research peptides manufactured in the USA?
Yes. All PX1 Research compounds are synthesized in GMP-compliant facilities in the United States and tested by independent third-party labs to ensure full analytical compliance.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.